We're at #ICML2023 all week and would love to meet up with folks interested in ML for drug discovery! Hit us up at our booth or one of the posters below 👋

Attending #NeurIPS2023? Don’t miss our spotlight poster, "Masked Autoencoders are Scalable Learners of Cellular Morphology" Paper: openreview.net/forum?id=jasx3… Where: GenBio workshop, Poster Session 1 in Room 265 - 268 When: Saturday, Dec 16th, 11:30 am - 1:30 pm CST.

At yesterday's standing-room-only #JPM24 talk by NVIDIA, Kimberly Powell announced the release of our #phenomics foundation model, Phenom-Beta, on NVIDIA's #BioNeMo platform. Learn more about the power of Phenom-Beta in our latest blog by Ben Mabey: recursion.com/news/nothing-s…

You have to have skin in the game! Reflecting back on #JPM2024 last week and this shot has to be a personal highlight. I was comparing company tattoos with NVIDIA founder & CEO Jensen Huang when Recursion Board Chair R. Martin Chavez dropped his full sleeve Turing machine!

Christmas has come *early*, yay for priority access! If you want to use these H100s to decode biology or help run the cluster with our amazing HPC team please apply! recursion.com//careers

On the compute side of things, I went to help setup our new cluster today with Berton Earnshaw! For some reason they didn't trust us to rack the DGX nodes so we settled for some garbage duty and I read the DGX H100 Quickstart Guide... going to get these new nodes training soon!

Big news on the People front as well, with Najat Khan joining the Recursion exec team and Board of Directors! Najat is incredibly talented and interdisciplinary with her unique blend of expertise in life sciences, data science & business, she is the perfect addition to our team.

People ✅ Data ✅ Compute ✅ Capital ✅ Pulled the last pieces of plastic off of BioHive-2 today as we finish up our Top500 benchmarking work. HUGE thanks to the dedicated team Recursion for the incredible push to get this across the line… and a big thank you to our

This work is the culmination of years of efforts in building powerful, expressive and scalable molecular GNNs. And we finally have it! A foundational GNN of 1B of parameters that achieves SOTA on a large diversity of tasks

“This is a once-in-a-lifetime opportunity.” In a Fireside Chat w/ Chris Gibson, Jensen Huang shared his vision for the future of healthcare – driven by #AI, #supercomputers, and a data-driven approach to #biology. #downloadday youtube.com/watch?v=Sr_n3g…

Today's benchmarking landscape for ML in drug discovery is complicated. We want to help the community develop methods that matter!🌟 Join us for our launch party at ICML on July 25th to learn more: lu.ma/wj1agv8o

1/ 🚀Today, we’re excited to launch Polaris! 🚀 Polaris is a platform where the ML community working on drug discovery problems can easily share and access datasets and benchmarks. Get started with just a few lines of code: polarishub.io

Announcing positive Phase 2 topline results for our first-in-disease treatment for cerebral cavernous malformation (#CCM) – the #AI drug discovery that launched our company. REC-994 met its primary endpoint of safety & tolerability & showed promising MRI-based secondary efficacy

A new article in Nature Biotechnology looks at the rise of #foundation models in #drug discovery, noting that unlike others using an #LLM framework, “Recursion is pursuing a radically different approach with its Phenom family of foundation models.” As Imran S. Haque (@ihaque@{bsky,genomic}.social) describes, our latest

The moment has finally arrived. Recursion has combined with Exscientia, giving rise to a new TechBio powerhouse! All the essential elements are now in place: an unwavering commitment to challenge the status quo; an interconnected end-to-end platform combining